Bhubaneswar, 5th Nov 2025: For the first time, an oral medication (Rybelsus) has been approved to reduce the risk of heart attack and stroke.
This tablet is primarily intended for people with type-2 diabetes who are also at risk of heart disease.
Previously, such benefits were available only through injections, but now, taking a single tablet daily without injection can help reduce this risk.
Research shows that this tablet can help lower the risk of major cardiovascular events by approximately 14Percent.
No responses yet